Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof

Details for Australian Patent Application No. 2010325787 (hide)

Owner Biogen Idec Hemophilia Inc.

Inventors Dumont, Jennifer A.; Low, Susan; Bitonti, Alan J.; Pierce, Glenn; Luk, Alvin; Jiang, Haiyan; Mckinney, Byron; Ottmer, Matt; Ommer, Jurg; Nugent, Karen; Li, Lian; Peters, Robert

Agent Cullens

Pub. Number AU-A-2010325787

PCT Pub. Number WO2011/069164

Priority 61/419,676 03.12.10 US; 61/410,929 07.11.10 US; 61/285,054 09.12.09 US; 61/301,592 04.02.10 US; 61/373,113 12.08.10 US; 61/267,070 06.12.09 US; 61/363,065 09.07.10 US

Filing date 6 December 2010

Wipo publication date 9 June 2011

International Classifications

C07K 14/755 Peptides having more than 20 amino acids

A61K 38/37 Medicinal preparations containing peptides

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/069164 Priority application(s): WO2011/069164

19 July 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the names Biogen Idec Hemophilia Inc., Application No. 2010325787, under INID (72) correct the co-inventors to McKinney, Byron; Sommer, Jurg

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010325790-Geotechnical horizontal directional drilling

2010325781-Cushioned absorbent mat